Skip to main content
Mark Faries, MD, General Surgery, Los Angeles, CA, Providence Saint John's Health Center

MarkBFariesMD

General Surgery Los Angeles, CA

Melanoma, Surgical Oncology (Other than Breast)

The Angeles Clinic and Research Institute / Cedars Sinai

Dr. Faries is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Faries' full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Surgery, 1995 - 2002
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2024
  • CT State Medical License
    CT State Medical License 2010 - 2015
  • PA State Medical License
    PA State Medical License 1996 - 2004
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Microsatellitosis in Patients with Melanoma  
    Richard L White, Mark B Faries, Stanley P Leong, Andrew J Sinnamon, Dale Han, Jane L Messina, Barbara A Pockaj, Giorgos C Karakousis, Edmund K Bartlett, John T Vetto, ..., Annals of Surgical Oncology

Press Mentions

  • GSK Presents Positive Efficacy Data of Dostarlimab in Mismatch Repair-Deficient (dMMR) Solid Cancers at ASCO Gastrointestinal Cancers Symposium
    GSK Presents Positive Efficacy Data of Dostarlimab in Mismatch Repair-Deficient (dMMR) Solid Cancers at ASCO Gastrointestinal Cancers SymposiumDecember 13th, 2019
  • Elios Therapeutics Announced That a Personalized Vaccine Reduced the Risk of Melanoma Recurrence in Patients with Previously Treated Disease
    Elios Therapeutics Announced That a Personalized Vaccine Reduced the Risk of Melanoma Recurrence in Patients with Previously Treated DiseaseJuly 17th, 2019
  • Lymph-Node Dissection Increases Rates of Regional Disease Control
    Lymph-Node Dissection Increases Rates of Regional Disease ControlSeptember 1st, 2017
  • Join now to see all

Professional Memberships

Hospital Affiliations